Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Colony Stimulating Factor 3 Receptor (Granulocyte) (CSF3R) (N-Term) Peptide

CSF3R Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN5511046

Quick Overview for Colony Stimulating Factor 3 Receptor (Granulocyte) (CSF3R) (N-Term) Peptide (ABIN5511046)

Target

CSF3R (Colony Stimulating Factor 3 Receptor (Granulocyte) (CSF3R))

Origin

Human

Source

  • 4
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Sequence

    HNLSCLMNLT TSSLICQWEP GPETHLPTSF TLKSFKSRGN CQTQGDSILD

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-CSF3R Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    CSF3R (Colony Stimulating Factor 3 Receptor (Granulocyte) (CSF3R))

    Background

    The protein encoded by this gene is the receptor for colony stimulating factor 3, a cytokine that controls the production, differentiation, and function of granulocytes. The encoded protein, which is a member of the family of cytokine receptors, may also function in some cell surface adhesion or recognition processes. Alternatively spliced transcript variants have been described. Mutations in this gene are a cause of Kostmann syndrome, also known as severe congenital neutropenia.

    Alias Symbols: CSF3R,GCSFR,

    Protein Size: 836

    Gene ID

    1441

    UniProt

    Q99062
You are here:
Chat with us!